ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367,384 | -24.1% | 19,720 | +2.2% | 0.00% | -50.0% |
| Q1 2022 | $484,000 | +131.6% | 19,288 | +292.0% | 0.00% | +100.0% |
| Q3 2021 | $209,000 | -59.6% | 4,921 | -58.8% | 0.00% | -50.0% |
| Q2 2021 | $517,000 | +116.3% | 11,936 | +103.6% | 0.00% | +100.0% |
| Q1 2021 | $239,000 | -1.6% | 5,862 | +9.1% | 0.00% | -50.0% |
| Q4 2020 | $243,000 | -83.4% | 5,373 | -80.9% | 0.00% | -77.8% |
| Q4 2019 | $1,460,000 | +82.0% | 28,153 | +92.7% | 0.01% | +28.6% |
| Q3 2019 | $802,000 | +170.9% | 14,608 | +49.1% | 0.01% | +133.3% |
| Q1 2019 | $296,000 | -59.2% | 9,800 | -54.6% | 0.00% | -62.5% |
| Q4 2018 | $725,000 | +38.4% | 21,563 | +104.7% | 0.01% | 0.0% |
| Q1 2018 | $524,000 | +49.3% | 10,536 | +61.8% | 0.01% | +33.3% |
| Q4 2017 | $351,000 | -14.0% | 6,510 | -7.5% | 0.01% | -25.0% |
| Q3 2017 | $408,000 | +92.5% | 7,037 | +77.9% | 0.01% | -38.5% |
| Q2 2016 | $212,000 | – | 3,955 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |